Differential senolytic inhibition of normal versus Aβ-associated cholinesterases: implications in aging and Alzheimer’s disease
Figure 1.Chemical structures of approved and investigational senolytic (1-5) and nootropic (6) agents. Structures were drawn using ChemDoodle: 2D Chemical Drawing, Publishing and Informatics (Version 11.10, iChemLabs, LLC, Somerset, NJ, USA).